Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma

Journal of Breast Cancer

Volumn 16, Issue 4, 2013, Pages 417-425

  Park, Inhye ^a   Kim, Jiyoung ^a   Kim, Minkuk ^a   Bae, Soo Youn ^a   Lee, Se Kyung ^a   Kil, Won Ho ^a   Lee, Jeong Eon ^a   Nam, Seok Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast neoplasms; Lymphatic metastasis; Medullary carcinoma; Prognosis

Indexed keywords

EID: 84892571466     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.4.417     Document Type: Article

References (27)

1. Tavassoli FA. Pathology of the Breast. 2nd ed. New York: McGraw-Hill; 1999. p.333-9.
2. Abdul Rashid S, Rahmat K, Jayaprasagam K, Alli K, Moosa F. Medullary carcinoma of the breast: role of contrast-enhanced MRI in the diagnosis of multiple breast lesions. Biomed Imaging Interv J 2009;5:e27.
3. Li CI. Risk of mortality by histologic type of breast cancer in the United States. Horm Cancer 2010;1:156-65.
4. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008;216:141-50.
5. Moore OS Jr, Foote FW Jr. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 1949;2:635-42.
6. Cotran RS, Kumar V, Collins T, Robbins SL. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: Saunders; 1999. p.1111.
7. Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977;40:1365-85.
8. Foschini MP, Eusebi V. Rare (new) entities of the breast and medullary carcinoma. Pathology 2009;41:48-56.
9. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005;93:1046-52.
10. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 2005;62:1040-7.
11. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 2007;194: 527-31.
12. Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10-year pathologic and clinical prognostic discriminants. Cancer 1993;71:2507-14.
13. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992;20:479-89.
14. Oh JW, Park S, Kim JH, Koo JS, Hur H, Yang WI, et al. Clinical analysis of medullary carcinoma of the breast. J Breast Cancer 2009;12:47-53.
15. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988;61:2503-10.
16. Edge SB; American Joint Committee on Cancer; American Cancer Society. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
17. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77.
18. Anderson WF, Chu KC, Chang S, Sherman ME. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:1128-35.
19. Korean Breast Cancer Society. Breast Cancer Facts & Figures. Seoul: Korean Breast Cancer Society; 2012.
20. Flucke U, Flucke MT, Hoy L, Breuer E, Goebbels R, Rhiem K, et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology 2010;56:852-9.
21. Malyuchik SS, Kiyamova RG. Medullary breast carcinoma. Exp Oncol 2008;30:96-101.
22. Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch 2005;446:10-4.
23. Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol 1995;60:89-94.
24. Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Öhlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012;23:2843-51.
25. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher B. Medullary cancer of the breast revisited. Breast Cancer Res Treat 1990;16: 215-29.
26. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 2004;59:152-9.
27. Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol 2011;28:738-44.